Publications

210x148 mm5_-01
Introducing the sporobiota and sporobiome

Gut Pathogens (2017)

395953677ASM Microbe 2017 - American Society For Microbiology Conference-1024x272 (1)
Introducing the Sporobiome: An Unexplored Nexus of Resistome and Novel Human Pathogens

ASM Microbe (2017)

ASM 2017-1
Infection of Microbiota by Bacteriophages Can Be Considered a New Group of Viral Diseases of Mammals Including Humans

ASM Microbe (2017)

genome-announcements-cover
Draft Genome Sequence of Bacillus obstructivus sp.nov. Isolated from the Bronchoalveolar Lavage Fluid of a Patient with COPD

Genome announcements (2017)

genome-announcements-cover
Draft Genome Sequence of Kluyvera intestini Strain GT-16 Isolated from the Stomach of a Patient with Gastric Cancer

Genome announcements (2016)

Genome announcements
Complete Genome Sequence of a Novel Bacillus sp. VT 712 Isolated from the Duodenum of a Patient with Intestinal Cancer

Genome announcements (2016)

1920x595 px-05
Bacteriophage infections of microbiota can lead to leaky gut in an experimental rodent model

Gut pathogens (2016)

alzheimer's
Effect of deoxyribonuclease I treatment for dementia in end-stage Alzheimer’s disease: a case report

Journal of Medical Case Reports (2016)

Antimicrobial activity of Mul-1867, a novel antimicrobial compound, against multidrug-resistant Pseudomonas aeruginosa

Annals of Clinical Microbiology and Antimicrobials (2016)

alzheimer's
Experimental treatment for dementia in end-stage Alzheimer’s disease: a case report

NEW YORK (May 5, 2016) – Human Microbiology Institute is delighted to announce that its scientific core played a primary role in the groundbreaking study for the treatment of dementia in end-stage Alzheimer’s disease.

123